AGCO (NYSE: AGCO), a worldwide manufacturer and distributor of
agricultural equipment, announces that Robert Crain, Senior Vice
President and General Manager, North America, will take over
responsibility for AGCO’s South America region from André Carioba,
Senior Vice President and General Manager, South America, effective
January 1, 2015.
Genetics, Inc. (Nasdaq: SGEN) and Takeda
Pharmaceutical Company Limited (TSE:4502) today reported data
demonstrating that Hodgkin lymphoma (HL) patients at risk of relapse
following an autologous stem cell transplant (ASCT) who received
ADCETRIS (brentuximab vedotin) as consolidation therapy immediately
after ASCT had significant improvement in progression-free survival
(PFS) compared to patients who received placebo (median of 43 months
versus 24 months, respectively; hazard ratio=0.57; p-value=0.001). The
data from the AETHERA trial were featured at the 56th American Society
of Hematology (ASH) Annual Meeting press program today and will be
presented in an oral session on December 8, 2014.
Sign-up for Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS® (Brentuximab Vedotin) in Post-Transplant Hodgkin Lymphoma Patients at Risk of Relapse at ASH Annual Meeting investment picks
Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company
focused on delivering innovative therapies to patients with kidney
disease through the biology of hypoxia inducible factor (HIF), today
announced that John P.
LifePoint Hospitals, Inc. (NASDAQ: LPNT) today announced that its
management will participate in the Bank of America Merrill Lynch 2014
Leveraged Finance Conference to be held December 1 - 3, 2014, in Boca
Sign-up for SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Nymox Pharmaceutical Corporation and Its Board of Directors and a Lead Plaintiff Deadline of January 26, 2015 -- NYMX investment picks
Sign-up for Stemline Therapeutics Announces Multiple Preclinical Presentations Highlighting Its Pipeline of IL-3R-Directed Therapeutics at the American Society of Hematology (ASH) Annual Meeting investment picks
Sign-up for FNFV Announces Closing of Sale of Comdata to FleetCor and Indirect Receipt of Approximately 2.4 Million Shares of FleetCor Common Stock Valued at Approximately $356 Million investment picks
Progress Software Corporation (NASDAQ:PRGS) today announced that it has
entered into a definitive agreement to acquire privately held Telerik
AD, a leading provider of application development tools, for $262.5
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.